Science & Innovation has decided to focus on several key areas: orthopaedics, oncology and ophthalmology to name a few.
Science and innovation are central to Swiss Medical Network’s activities. Investment in quality research is essential to ensure that diagnostic methods are constantly improved and that the most innovative and safest therapeutic solutions are implemented.
Swiss Medical Network has consolidated its research activity by creating Science & Innovation.
The activities of this new scientific platform are divided into four main areas:
The Clinique Générale-Beaulieu's Radixact tomotherapy (the only tomotherapy radiotherapy equipment in Geneva) will now be fully controlled by Raysearch's RayCare. Considered a pioneer, the Clinique Générale-Beaulieu is the first clinic in the world to have fully integrated and used RayCare.
Science & Innovation has decided to focus on several key areas: orthopaedics, oncology and ophthalmology to name a few.
Professor Guido Garavaglia, Head of Teaching and Research at Clinica Ars Medica, Gravesano, and Professor at the Faculty of Medicine, University of Geneva, developed an IT platform for the implementation of systematic PROM (Patient-Reported Outcome Measures) data collection for all types of clinical activities.
Dr Matti Aapro (Clinique de Genolier) published a large number of peer-reviewed articles in various domains of medical oncology. His numerous research programs in geriatric oncology, breast cancer management and supportive care bear witness to his experience in clinical research protocols and educational activities
“With over 95 scientific publications since 2018, the Swiss Visio Montchoisi Glaucoma Research Centre has quickly become one of the most active centres in Switzerland (and one of the three most active centres in Europe) in this field.” Prof. K. Mansouri
Swiss Medical Network’s clinical research programmes are conducted in close collaboration with leading organisations. In Switzerland, these include:
On an international scale, the Group works with the European Organisation for Research and Treatment of Cancer (EORTC) and academic institutions based in New York and Houston.
Lea Sprunger, European champion of the 400-metre hurdles, manages her health capital at the Clinique de Genolier.
Specialist in Radio-Oncology and Nuclear Medicine from the University of Liège in Belgium, Jacques Bernier is the Swiss Medical Network’s Chief Science Officer. From 2006 till 2019, he is Head of the Radiation Oncology Department at the Clinique de Genolier and Medical Director of Centre d’Oncologie des Eaux-Vives in Geneva.
In 2010, he is awarded the “Claudius Regaud Medal” by the European Society of Therapeutic Radiology and Oncology - ESTRO. From 2016 till 2019, he is President of the Euro-Asian Society of Mastology – EURAMA, based in Milan. He also chairs the Genolier Cancer Center till 2019.